Skip to main content
OpenTrials

Clinical trial condition

Meningococcal Infections

Explore clinical trials studying Meningococcal Infections. Study availability and eligibility vary by location and protocol.

52 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Meningococcal Infections trial results

Completed

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

NCT00161928

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • Freistädter Strasse 290 Linz, Austria
  • Grieskirchner Strasse 17 Wels, Austria
  • Neuschwansteinstrasse 5 Augsburg, Germany
  • Marktplatz 3 Bad Saulgau, Germany
View all 14 locations
View Trial Details
Completed

Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216

NCT00161941

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Grieskirchner Strasse 17 Wels, Austria
  • Neuschwansteinstrasse 5 Augsburg, Germany
  • Marktplatz 3 Bad Saulgau, Germany
  • Hauptrasse 9 Bietigheim-Bissingen, Germany
View Trial Details
Completed

A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents

NCT00808028

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • Queensland Paediatric Infectious Diseases (QPID) Laboratory Herston, Queensland, Australia
  • Department of Paediatrics, Women's & Children's Hospital North Adelaide, South Australia, Australia
  • Royal Children's Hospital Carlton, Victoria, Australia
  • Children's Clinical Research Facility, Vaccine Trials Group (VTG), Subiaco, Western Australia, Australia
View all 27 locations
View Trial Details
Completed

A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years

NCT01352793

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • Accelovance,Inc. Huntsville, Alabama, United States
  • Clinical Research Advantage, Inc. / East Valley Family Physicians, PLC Chandler, Arizona, United States
  • Clinical Research Advantage, Inc/ East Valley Family Physicians, PLC Chandler, Arizona, United States
  • Cassidy Medical Group/Clinical Research Advantage Tempe, Arizona, United States
View all 86 locations
View Trial Details
Completed

A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents

NCT01424644

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +19 more
Locations
  • Birmingham Pediatrics, 806 Saint Vincent's Drive, Suite 615 Birmingham, Alabama, United States
  • Prairie Fields Family Medicine, 350 W. 23rd Street, Suite A Fremont, California, United States
  • Madera Family Medical Group, 1111 W. Fourth Street Madera, California, United States
  • Clinical Research Advantage / Colorado Springs Health Partners, 6340 Barnes Road Colorado Springs, Colorado, United States
View all 20 locations
View Trial Details

Related conditions